Wilson Sonsini Goodrich & Rosati advised XinThera on the transaction. Gilead Sciences announced the acquisition of San Diego-based XinThera, a privately held biotech company. The acquisition...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here